Single‐step purification and structural characterization of human interleukin‐6 produced in Esherichia coli From a T7 RNA polymerase expression vector R Arcone, P Pucci, F Zappacosta, V Fontaine, A Malorni, G Marino, ... European journal of biochemistry 198 (3), 541-547, 1991 | 193 | 1991 |
Development of a human interleukin-6 receptor antagonist. JP Brakenhoff, FD De Hon, V Fontaine, E Ten Boekel, H Schooltink, ... Journal of Biological Chemistry 269 (1), 86-93, 1994 | 147 | 1994 |
In vitro methods for the evaluation of antimicrobial surface designs J Sjollema, SAJ Zaat, V Fontaine, M Ramstedt, R Luginbuehl, ... Acta Biomaterialia 70, 12-24, 2018 | 130 | 2018 |
Effects of HPV-16 E5, E6 and E7 proteins on survival, adhesion, migration and invasion of trophoblastic cells S Boulenouar, C Weyn, M Van Noppen, M Moussa Ali, M Favre, ... Carcinogenesis 31 (3), 473-480, 2010 | 121 | 2010 |
Evolution of the human immunodeficiency virus type 1 long terminal repeat promoter by conversion of an NF-κB enhancer element into a GABP binding site K Verhoef, RW Sanders, V Fontaine, S Kitajima, BEN Berkhout Journal of virology 73 (2), 1331-1340, 1999 | 101 | 1999 |
Analysis of the human interleukin-6/human interleukin-6 receptor binding interface at the amino acid level: proposed mechanism of interaction M Kalai, FA Montero-Julian, J Grötzinger, V Fontaine, P Vandenbussche, ... Blood, The Journal of the American Society of Hematology 89 (4), 1319-1333, 1997 | 84 | 1997 |
Evaluation of combined general primer-mediated PCR sequencing and type-specific PCR strategies for determination of human papillomavirus genotypes in cervical cell specimens V Fontaine, C Mascaux, C Weyn, A Bernis, N Celio, P Lefevre, L Kaufman, ... Journal of clinical microbiology 45 (3), 928-934, 2007 | 79 | 2007 |
Evidence of human papillomavirus in the placenta C Weyn, D Thomas, J Jani, M Guizani, C Donner, M Van Rysselberge, ... Journal of Infectious Diseases 203 (3), 341-343, 2011 | 72 | 2011 |
A functional NF-κB binding site in the human papillomavirus type 16 long control region V Fontaine, E van der Meijden, J de Graaf, J ter Schegget, L Struyk Virology 272 (1), 40-49, 2000 | 59 | 2000 |
Involvement of the Arg179 in the active site of human IL‐6 V Fontaine, R Savino, R Arcone, L De Wit, JPJ Brakenhoff, J Content, ... European journal of biochemistry 211 (3), 749-755, 1993 | 55 | 1993 |
Chemical constituents, cytotoxic, antifungal and antimicrobial properties of Centaurea diluta Ait. subsp. algeriensis (Coss. & Dur.) Maire H Zater, J Huet, V Fontaine, S Benayache, C Stévigny, P Duez, ... Asian Pacific journal of tropical medicine 9 (6), 554-561, 2016 | 50 | 2016 |
Increased vancomycin susceptibility in mycobacteria: a new approach to identify synergistic activity against multidrug-resistant mycobacteria K Soetaert, C Rens, XM Wang, J De Bruyn, MA Lanéelle, F Laval, ... Antimicrobial Agents and Chemotherapy 59 (8), 5057-5060, 2015 | 49 | 2015 |
Detection of HPV and the role of p16INK4Aoverexpression as a surrogate marker for the presence of functional HPV oncoprotein E7 in colorectal cancer V Deschoolmeester, V Van Marck, M Baay, C Weyn, P Vermeulen, ... BMC cancer 10, 1-10, 2010 | 49 | 2010 |
Effects of lipid-lowering drugs on vancomycin susceptibility of mycobacteria C Rens, F Laval, M Daffé, O Denis, R Frita, A Baulard, R Wattiez, ... Antimicrobial agents and chemotherapy 60 (10), 6193-6199, 2016 | 40 | 2016 |
Modulation of Interleukin‐6 Receptors in Human Cellsa L Snyers, V Fontaine, J Content Annals of the New York Academy of Sciences 557 (1), 388-395, 1989 | 35 | 1989 |
Evaluation of the self-sampling for cervical cancer screening in Bolivia G Allende, P Surriabre, L Cáceres, D Bellot, N Ovando, A Torrico, P Calle, ... BMC Public Health 19, 1-9, 2019 | 33 | 2019 |
Isoniazid bactericidal activity involves electron transport chain perturbation S Zeng, K Soetaert, F Ravon, M Vandeput, D Bald, JM Kauffmann, ... Antimicrobial agents and chemotherapy 63 (3), 10.1128/aac. 01841-18, 2019 | 33 | 2019 |
Efficiency of an inexpensive liquid-based cytology performed by cytocentrifugations: a comparative study using the histology as reference standard C Garbar, C Mascaux, V Fontaine Cytojournal 2, 15, 2005 | 33 | 2005 |
Antibacterial and cytotoxic activities of ten commercially available essential oils S Oliveira Ribeiro, V Fontaine, V Mathieu, A Zhiri, D Baudoux, C Stévigny, ... Antibiotics 9 (10), 717, 2020 | 31 | 2020 |
Analysis of the Mechanism of Action of Anti‐human Interleukin‐6 and Anti‐human Interleukin‐6 Receptor‐neutralising Monoclonal Antibodies M Kalai, FA Montero‐julian, JPJ Brakenhoff, V Fontaine, L De Wit, ... European journal of biochemistry 249 (3), 690-700, 1997 | 30 | 1997 |